Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D07XWB
|
||||
| Former ID |
DNC013065
|
||||
| Drug Name |
4-(thiazol-2-yl)phenyl butylcarbamate
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [528323] | ||
| Formula |
C14H16N2O2S
|
||||
| Canonical SMILES |
CCCCNC(=O)OC1=CC=C(C=C1)C2=NC=CS2
|
||||
| InChI |
1S/C14H16N2O2S/c1-2-3-8-16-14(17)18-12-6-4-11(5-7-12)13-15-9-10-19-13/h4-7,9-10H,2-3,8H2,1H3,(H,16,17)
|
||||
| InChIKey |
HIQUBTZOYOZSPC-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [528323] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||